Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

10.5%

2 terminated/withdrawn out of 19 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

37%

7 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
7(50.0%)
N/A
3(21.4%)
Phase 1
2(14.3%)
Phase 2
2(14.3%)
14Total
Phase 4(7)
N/A(3)
Phase 1(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07055542Not ApplicableRecruiting

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Role: collaborator

NCT07254000Phase 2Recruiting

Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants

Role: lead

NCT05394363Recruiting

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

Role: collaborator

NCT05565430Completed

Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.

Role: lead

NCT01420367Not ApplicableCompleted

Are Post-operative Antibiotics Indicated in Simple Appendicitis?

Role: collaborator

NCT05280340Phase 1Active Not Recruiting

Anakinra for Preterm Infants Pilot

Role: lead

NCT01568307Phase 4Completed

Major Depressive Disorder - Understanding The Link Between The Brain And The Heart

Role: collaborator

NCT05557097Unknown

PROPENSITY-ID: Sonographic and Clinical Assessment of Head Position Prior to Instrumental Delivery and Labour Outcomes

Role: collaborator

NCT03003026Not ApplicableCompleted

Bike Skills Training for Children With Cerebral Palsy

Role: collaborator

NCT04968522Phase 4Unknown

FASST - Fetal Alcohol Spectrum Stimulant Trial

Role: lead

NCT04796636Phase 1Unknown

High-dose Intravenous Vitamin C in Patients With Septic Shock

Role: collaborator

NCT02140580Phase 4Unknown

OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Role: collaborator

NCT01567124Phase 4Withdrawn

Alleviating the Metabolic Side Effects of Antipsychotic Medications

Role: collaborator

NCT01896986Terminated

HPV Vaccination in Special Risk Groups: 5 Year Follow-up

Role: collaborator

NCT00662194Unknown

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

Role: collaborator

NCT01483053Phase 4Unknown

Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

Role: collaborator

NCT01451801Phase 4Unknown

Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders

Role: collaborator

NCT01252420Phase 4Unknown

Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis

Role: lead

NCT00371904Phase 2Unknown

Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients

Role: collaborator

All 19 trials loaded